MedTech Strategy Roundtables - San Francisco

ABOUT THE EVENT

Date: Monday, September 22, 2025 8am–5:50pm PDT
Event Location: San Francisco , California

hubXchange is pleased to present the MedTech Strategy Xchange – San Francisco 2025, a high-level, invitation-only event tailored for senior executives and scientists. This unique forum explores the most pressing scientific and strategic challenges across the Medical Technology.

Focus Tracks

  • Regulatory Strategy

  • Clinical Validation & Trial Design

  • Product Development & Device Engineering

  • Supply Chain

  • Scalable Manufacturing

🔹 Why Attend?

✅ Join thought-provoking roundtables led by leading researchers and developers
✅ Discover emerging tools, technologies, and delivery systems in nucleic acid and peptide therapeutics
✅ Network in pre-booked 1:1 meetings with key stakeholders
✅ Explore cutting-edge poster and spotlight presentations
✅ Collaborate on next-gen delivery, safety, and scalability solutions

🔹 Agenda Highlights?

  • Roundtable topics include:

    • First FDA interactions for early-stage companies

    • Bridging device innovation with behavioral health trial design

    • Integrating human factors into the product development lifecycle

    • Design choices that impact scalability from the outset

    • Best practices for demand forecasting and inventory planning

    • Strategies for reducing rework costs in device design

    • Regulatory strategy informed by medical insights

    • Selecting effective clinical trial endpoints

  • Spotlight presentations on secure medical device development

  • Pre-arranged 1:1 meetings and networking opportunities throughout

  • Drinks and canapé reception to close the event

MORE EVENTS
This webinar, tailored for scientists in academia, biotech, and pharma, will explore how intelligent mRNA designs can reduce experimental workloads and improve mRNA performance and efficacy.
Wednesday, October 15, 2025 11am–12pm EDT
 · 
Virtual
BioSpace sits down with former FDA Chief Information Officer Vid Desai to discuss the potential advantages and pitfalls of deregulation stemming from one of President Donald Trump’s first executive orders. We will uncover what this shift means for drugmakers, compliance and patient safety.
Thursday, October 16, 2025 2–3pm EDT
 · 
Virtual
Research teams around the world are focused on the power of mRNA. As mRNA continues to enter and be adopted by the global healthcare community, the need to quickly validate and scale these therapeutics becomes more critical. This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
Wednesday, October 22, 2025 12–1pm EDT
 · 
Virtual